Protease Activated Receptor-1 Inhibits the Maspin Tumor-Suppressor Gene to Determine the Melanoma Metastatic Phenotype

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1006886108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

The FBXO4 Tumor Suppressor Functions as a Barrier to BrafV600E-Dependent Metastatic Melanoma

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

Erratum To: Protease-Activated-Receptor-2 Affects Protease-Activated-Receptor-1-Driven Breast Cancer

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2016English

Protease-Activated Receptor 1 (PAR1)

Science-Business eXchange
2012English

Protease-Activated Receptor-1 Regulates Cytokine Production and Induces the Suppressor of Cytokine Signaling-3 in Microglia

International Journal of Molecular Medicine
MedicineGenetics
2009English

Matrix Metalloproteinase 1 (MMP1); Protease-Activated Receptor 1 (PAR1)

Science-Business eXchange
2009English

Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells

International Journal of Cancer
Cancer ResearchOncology
2018English

Protease-Activated Receptor 1-Dependent Neuronal Damage Involves NMDA Receptor Function

Experimental Neurology
Developmental NeuroscienceNeurology
2009English

The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell–Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth

Frontiers in Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy